This dual-dataset methodology not only strengthens the reliability of the findings but also emphasizes the translational potential of epigenetic biomarkers including LDHC and SLC35G2 in clinical implementations for food allergy diagnosis and treatment. This evidence concerns the gene SLC35G2 and allergic disease.